U.S. flag

An official website of the United States government

NM_000089.4(COL1A2):c.293dup (p.Pro98_Arg99insTer) AND Ehlers-Danlos syndrome, cardiac valvular type

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Jul 1, 2006
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000018821.32

Allele description [Variation Report for NM_000089.4(COL1A2):c.293dup (p.Pro98_Arg99insTer)]

NM_000089.4(COL1A2):c.293dup (p.Pro98_Arg99insTer)

Gene:
COL1A2:collagen type I alpha 2 chain [Gene - OMIM - HGNC]
Variant type:
Duplication
Cytogenetic location:
7q21.3
Genomic location:
Preferred name:
NM_000089.4(COL1A2):c.293dup (p.Pro98_Arg99insTer)
HGVS:
  • NC_000007.14:g.94404569dup
  • NG_007405.1:g.15009dup
  • NM_000089.4:c.293dupMANE SELECT
  • NP_000080.2:p.Pro98_Arg99insTer
  • NP_000080.2:p.Pro98_Arg99insTer
  • LRG_2t1:c.293dup
  • LRG_2:g.15009dup
  • LRG_2p1:p.Pro98_Arg99insTer
  • NC_000007.13:g.94033881dup
  • NM_000089.3:c.293dup
Note:
NCBI staff reviewed the sequence information reported in PubMed 16816023 Fig. 4 to determine the location of this allele on the current reference sequence.
Links:
OMIM: 120160.0052; dbSNP: rs797044459
NCBI 1000 Genomes Browser:
rs797044459
Molecular consequence:
  • NM_000089.4:c.293dup - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Name:
Ehlers-Danlos syndrome, cardiac valvular type
Synonyms:
Ehlers-Danlos syndrome, autosomal recessive, cardiac valvular form
Identifiers:
MONDO: MONDO:0009159; MedGen: C4303789; Orphanet: 230851; OMIM: 225320

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000039104OMIM
no assertion criteria provided
Pathogenic
(Jul 1, 2006)
germlineliterature only

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only

Citations

PubMed

Total absence of the alpha2(I) chain of collagen type I causes a rare form of Ehlers-Danlos syndrome with hypermobility and propensity to cardiac valvular problems.

Malfait F, Symoens S, Coucke P, Nunes L, De Almeida S, De Paepe A.

J Med Genet. 2006 Jul;43(7):e36.

PubMed [citation]
PMID:
16816023
PMCID:
PMC2564565

Details of each submission

From OMIM, SCV000039104.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)

Description

In a 6-year-old male with cardiac valvular type of Ehlers-Danlos syndrome (EDSCV; 225320), who had a clinical phenotype of the hypermobile (arthrochalasis) type of EDS, Malfait et al. (2006) found a total absence of the alpha-2 chain of type I collagen. Molecular studies demonstrated a homozygous insertion of a C (292_293insC) at codon 8 of COL1A2 exon 7. The resulting frameshift introduced a premature termination codon in the next amino acid position. Both first-cousin parents carried the same insertion in heterozygous state. Since some signs of mitral valve bulging were present already in the patient at the age of 6 years, cardiac follow-up by echocardiography was proposed for patients with complete absence of alpha-2 chains of type I collagen.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

Last Updated: Aug 5, 2023